Virus-like Vesicles Expressing Multiple Antigens for Immunotherapy of Chronic Hepatitis B

Infections with hepatitis B virus (HBV) can initiate chronic hepatitis and liver injury, causing more than 600,000 deaths each year worldwide. Current treatments for chronic hepatitis B are inadequate and leave an unmet need for immunotherapeutic approaches. We designed virus-like vesicles (VLV) as...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:iScience
मुख्य लेखकों: Yarovinsky, Timur O., Mason, Stephen W., Menon, Manisha, Krady, Marie M., Haslip, Maria, Madina, Bhaskara R., Ma, Xianyong, Moshkani, Safiehkhatoon, Chiale, Carolina, Pal, Anasuya Chattopadhyay, Almassian, Bijan, Rose, John K., Robek, Michael D., Nakaar, Valerian
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Elsevier 2019
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889364/
https://ncbi.nlm.nih.gov/pubmed/31704650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2019.10.040
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन